Stay updated with breaking news from Multiple Ascending Dose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AlzeCure presents new clinical data with ACD856 at Alzheimer's conferenceAlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the central nervous system, with projects in both Alzheimer’s disease and pain,...
STOCKHOLM, SWEDEN / ACCESSWIRE / March 8, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates
PRESS RELEASE February 24, 2022 Three Months Ended December 31, 2021 (2020) Revenue was SEK 2.9 M (1.6 M)Operating loss was SEK -125.7 M (-68.6 M)Net loss was SEK -129.9 M (-44.4 M)Basic
Inhaled Niclosamide Demonstrates Potent Activity Against Omicron Variant Dosing of Inhaled Niclosamide Estimated to Produce Concentrations in Excess of...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.